Revista de Investigación Clínica (Jan 2022)

Severe congenital neutropenia type 4: a rare disease harboring a G6pc3 gene pathogenic variant particular to the mexican population

  • Larissa López-Rodríguez,
  • Yevgeniya Svyryd,
  • Edmar O. Benítez-Alonso,
  • Pamela Rivero-García,
  • Leonora Luna-Muñoz,
  • Osvaldo M. Mutchinick

DOI
https://doi.org/10.24875/RIC.22000234
Journal volume & issue
Vol. 74, no. 6

Abstract

Read online

Background: Severe congenital neutropenia type 4 (SCN4) is a rare autosomal recessive granulopoiesis disorder caused by G6PC3 gene pathogenic variants. The estimated prevalence is 1/10,000,000 people. Over 90% of patients present a syndromic form with variable multisystemic involvement, including congenital heart defects, increased visibility of superficial veins (IVSV), inflammatory bowel disease, and congenital urogenital defects as prominent symptoms. Objectives: The objective of the study was to study non-hematological phenotypic findings that suggest a clinical diagnosis of SCN4. Methods: We examined medical records of patients diagnosed with neutropenia from January 2000 to December 2020, selecting cases with nonhematologic manifestations for phenotypic description and G6PC3 gene sequencing. Results: We found 11 cases with nonhematologic features: congenital heart defects in 8, IVSV in 6, inflammatory bowel disease in 4, urogenital defects in 4, and similar facial appearance. In addition, Sanger sequencing confirmed 3 homozygous cases for the c.210delC variant, a compound heterozygous harboring this variant, and a c.199_218+1 deletion. Conclusions: Our findings of the c.210delC variant in very close geographical settings, to date, have only been reported among Mexicans, and a mutual uncommon surname in two families strongly supports a founder effect for the variant in the studied population. Furthermore, the described non-hematologic symptoms in patients with severe primary neutropenia should be explored, confirming SCN4 by investigating G6PC3 gene mutations.

Keywords